BGIM
CELG

Boussard & Gavaudan Investment Management’s Celgene Corp CELG Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,558,564
Closed -$253M – 36
2019
Q3 		$253M Buy
2,558,564
+294,010
+13% +$27.9M 33.97% 1
2019
Q2 		$209M Buy
2,264,554
+313,096
+16% +$29.7M 32.11% 1
2019
Q1 		$186M Buy
+1,951,458
New +$171M 6.24% 2
2015
Q1 		– Sell
-1,947
Closed -$221K – 66
2014
Q4 		$221K Sell
1,947
-1,247
-39% -$132K 0.14% 23
2014
Q3 		$304K Buy
+3,194
New +$288K 0.18% 12

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Boussard & Gavaudan Investment Management's CELG Position: Q4 2019 in Review

Boussard & Gavaudan Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,558,564 shares — an estimated $253M sold.

Boussard & Gavaudan Investment Management first reported a position in CELG in Q3 2014 and held it in 5 quarters. The position peaked at $253M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Boussard & Gavaudan Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Boussard & Gavaudan Investment Management sold 2,558,564 Celgene Corp shares in Q4 2019, an estimated $253M.
  • Boussard & Gavaudan Investment Management first reported a position in Celgene Corp in Q3 2014 and held it in 5 quarters.
  • Boussard & Gavaudan Investment Management's Celgene Corp position peaked at $253M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q4 2019, filed 12 Feb 2020.